Elon Musk’s brain-computer interface technology firm Neuralink is soon to make a monumental leap ahead.
The startup recently revealed plans to commence volume production of its brain chips later this year, marking the end of trials and the entry of this revolutionary technology into mainstream use.
Musk revealed the vision plan on the X social networking site, X, when he stated that the plan for the Neurological Technology Company, or Neuro Tech, was to have all its surgical procedures almost entirely automated by the year 2026.
In addition, the implants would also be re-designed to easily pass through the dura, the hard outer covering of the brain, without having to first remove the dura.
The dura mater plays a crucial role as a protective barrier for the brain from infections as well as physical injury. It is a significant technical success to find a way to work around it instead of trying to go through it to make the procedure safer and more available.
How Neuralink is Restoring Independence Through Thought?
Neuralink is not only talking about the future, but they’re also delivering real outcomes today. In November of last year, they announced they had implanted the brain chip in 12 patients that suffer from severe paralysis, and they’re seeing a dramatic improvement in these patients’ ability to be more independent.
Mr. Arbaugh, who broke a record of sorts by becoming the first person implanted with Neuralink technology, has a lot of experience with this technology and has accumulated some fascinating insights on how this technology has managed to change his life dramatically.
After this implant, he can play games such as Mario Kart, control his television, and command his home appliances without having to move his body in any manner.
The implants allow users to control devices solely by thought. They can use the internet, update social websites, operate a computer mouse, as well as play video games, simply by using neural signals detected by the implant chip.
How 1,024 Electrodes are Redefining Brain-Body Communication?
The core component of Neuralink’s technology is the N1 chip, which has been first unveiled in 2022. This highly advanced technology comes equipped with 1,024 electrodes and 64 thin threads that directly link to the brain. These threads are thinner than human hair and thus can directly interact with brain cells without causing much damage to the cells.
“The motor cortex technology has been developed to assist patients with spinal cord injuries or any other condition that prevents messages passing from the brain to the body.” The technology helps to close the gap that prevents the nerves from working. Therefore, the body can function without the nerves.
Musk’s plans for Neuralink go far beyond the ability to help paralyzed individuals control a computer. Musk has stated that the technology could potentially one day offer full body functionality for the severely disabled.
“Neuralink is able to basically bridge the communication that comes out of the cortex, beyond the point in the neck and spinal column, where the nerves are severed,” Musk said in a recent posting. This means that paralyzed people could possibly regain control of their legs and arms by bypassing areas of damaged spinal cords with this technology.
Solving the Neuralink Affordability Equation
This shift in transitioning from low-volume to high-volume production represents a defining moment for Neuralink. Although the firm has managed to prove its technology effective in humans, mass production of these complex devices is a completely different story. This automated surgery procedure, which Neuralink is working on, will be critical in addressing the affordability element in making these devices more available to potential beneficiaries.
The timing of this announcement is important. With the necessary regulatory approvals on the endearment level to conduct human tests and the accumulation of evidence regarding safety and efficacy, Neuralink is ready to transition from the experimental stage to the operational stage.
For the estimated millions of people living with paralysis, spinal cord injuries, or severe motor disorders, the developments at Neuralink are a beacon of hope. Neuralink’s medical technologies are not simply offering improved quality-of-life enhancements but are on the cusp of offering life-transforming abilities.
As Neuralink readies the jump to scale-up production, concerns have been expressed regarding its eventual cost, accessibility, as well as its ultimate safety for the user. Yet the fact that it has been able to develop its technology to the functional prototype stage in so brief a period is indicative of the swift progress being made in brain-computer interface technology.
The process of an experimental device to a mainstream medical tool is a very protracted one, but the fact that Neuralink has announced plans to go into mass production indicates that the future may be nearer than one thought.
